Business Context and Reporting Period
This Form 8-K Current Report was filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) on April 15, 2022, reporting events occurring on April 14 and April 15, 2022. The filing addresses changes to the composition of the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and director compensation arrangements.
Material Changes
- Director Retirement: Stephen Block notified the Company of his intention to retire from the Board effective at the 2022 Annual Meeting. He will not stand for re-election. His departure is not due to any disagreement with the Company.
- Director Appointments: The Board appointed Kristin Patrick and Ann Cohen as directors effective April 15, 2022, to serve until the Annual Meeting.
- Committee Assignments: Ms. Patrick was appointed to the Nominating and Corporate Governance Committee. Ms. Cohen was appointed to the Audit Committee and is deemed independent under Rule 10A-3.
Compensation and Governance Details
Under the Non-Employee Director Compensation Policy, the new directors will receive:
- Annual Retainer: $40,000 for Board service.
- Committee Fees: $5,000 annually for the Nominating Committee (Ms. Patrick) and $10,000 annually for the Audit Committee (Ms. Cohen).
- Stock Options:
- Initial grant of 40,000 shares each, vesting in equal annual installments over three years.
- Annual grant of 20,000 shares each at each annual meeting, vesting over one year.
- Exercise price equals the fair market value on the grant date.
Both directors will enter into the Company's standard indemnification agreement.
Investor Verification Checklist
- Verify the exact date of the 2022 Annual Meeting to confirm the effective date of Stephen Block's retirement.
- Confirm the independence status of Ann Cohen regarding Audit Committee requirements under Rule 10A-3.
- Review the Company's Amended and Restated Non-Employee Director Compensation Policy (Exhibit 10.4 to the August 9, 2018 10-Q) for full terms.
- Check subsequent filings to confirm if the new directors were elected at the Annual Meeting.